USJECT Trademark

Trademark Overview

On Friday, October 6, 2023, a trademark application was filed for USJECT with the United States Patent and Trademark Office. The USPTO has given the USJECT trademark a serial number of 98213343. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, June 10, 2026. This trademark is owned by UNITHER PHARMACEUTICALS. The USJECT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research and development of injection devices for pharmaceutical use
usject

General Information

Serial Number98213343
Word MarkUSJECT
Filing DateFriday, October 6, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, June 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements

Pseudo MarkUS INJECT
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research and development of injection devices for pharmaceutical use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 15, 2023
Primary Code042
First Use Anywhere DateTuesday, September 12, 2023
First Use In Commerce DateTuesday, September 12, 2023

Trademark Owner History

Party NameUNITHER PHARMACEUTICALS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address80084 AMIENS -
FR
Party NameUNITHER PHARMACEUTICALS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address80084 AMIENS
FR

Trademark Events

Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Sunday, October 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2024ASSIGNED TO EXAMINER
Tuesday, May 28, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 28, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, May 28, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 28, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, December 5, 2024SOU EXTENSION 1 FILED
Thursday, December 5, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 25, 2025SOU TEAS EXTENSION RECEIVED
Monday, August 25, 2025SOU EXTENSION 2 FILED
Monday, August 25, 2025SOU EXTENSION 2 GRANTED
Tuesday, August 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 26, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, February 26, 2026USE AMENDMENT FILED
Wednesday, June 10, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 10, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 10, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

usject pharmaceutical development research product evaluation devices medicines injection preparations evaluations